{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:18:36Z","timestamp":1777911516465,"version":"3.51.4"},"reference-count":16,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Educ"],"published-print":{"date-parts":[[1995,2]]},"abstract":"<jats:p>This study was designed to compare sulfonylurea adherence assessment by providers, patients' self-report, pill counts, and a medication event monitoring system (MEMS-3\u00ae) device, and correlate the estimates of metabolic control by provider, patient, and laboratory. Forty-seven outpatient veterans with fair to poor metabolic control of non-insulin-dependent diabetes mellitus were enrolled and received monthly refills of sulfonylurea in vials with a cap containing an electronic medication monitoring microprocessor. Pill counts and fasting plasma glucoses were measured monthly, and glycohemoglobin and a 24-hour diet recall were obtained at 0 and 60 days. Investigators then asked providers and patients to assess adherence and metabolic control. Forty-seven percent were nonadherent to medication using MEMS-3\u00ae, 29% using pill counts, 29% using provider assessment, and 31 % using self-report. Thirty-one percent of providers and 53% of patients assessed metabolic control differently than laboratory values. Assessment of medication adherence by provider, patient, and pill counts did not explain metabolic control as closely as assessment by MEMS-3\u00ae.<\/jats:p>","DOI":"10.1177\/014572179502100109","type":"journal-article","created":{"date-parts":[[2007,3,18]],"date-time":"2007-03-18T04:00:53Z","timestamp":1174190453000},"page":"52-57","source":"Crossref","is-referenced-by-count":50,"title":["Assessment of Sulfonylurea Adherence and Metabolic Control"],"prefix":"10.1177","volume":"21","author":[{"given":"Barbara J.","family":"Mason","sequence":"first","affiliation":[{"name":"State University college of Pharmacy"}]},{"given":"Joy R.","family":"Matsuyama","sequence":"additional","affiliation":[{"name":"Saint Alphonsus Medical Center Boise, Idaho"}]},{"given":"Sandra G.","family":"Jue","sequence":"additional","affiliation":[{"name":"State University college of Pharmacy"}]}],"member":"179","published-online":{"date-parts":[[1995,2,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1177\/10600280930270S901","volume":"27","author":"Berf JS","year":"1993","journal-title":"Ann Pharmacother"},{"key":"atypb2","unstructured":"Emerging issues in pharmaceutical cost containment. Reston, Va: National Pharmaceutical Council 1992;2(2):1-16."},{"issue":"6","key":"atypb3","first-page":"1","volume":"10","author":"Leichter SB","year":"1991","journal-title":"Practical Diabetol"},{"key":"atypb4","first-page":"21","volume":"102","author":"Pendleton L.","year":"1987","journal-title":"Public Health Rep"},{"key":"atypb5","unstructured":"Sackett DL, Snow JC The magnitudes of compliance and noncompliance. In: Haynes RB, et al, eds. Compliance with health care. Baltimore: John Hopkins University Press, 1979:11-22."},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/1.3.309"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.121"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.122"},{"key":"atypb9","volume-title":"The physician's guide to non-insulin-dependent diabetes (type II) diagnosis and treatment","author":"Rifkin H.","year":"1988"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302700705"},{"key":"atypb11","unstructured":"Glasgow RE Compliance to diabetes regimens: conceptualization, complexity, and determinants of patient compliance in medical practice and clinical trials. In: Cramer JA, et al, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991:209-24."},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.191"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1177\/014572178801400213"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6447.728"},{"key":"atypb15","unstructured":"Haynes RB Treatment adherence: terminology, incidence, and conceptualization. In: Meichenbaum D, Turk DC, eds. Facilitation, treatment adherence: a practitioners' guidebook. New York: Plenum Press , 1978: 19-40."},{"key":"atypb16","first-page":"600","volume":"20","author":"Levy M.","year":"1982","journal-title":"Int J Clin Pharmacol Ther Toxicol"}],"container-title":["The Diabetes Educator"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/014572179502100109","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/014572179502100109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:27:40Z","timestamp":1777649260000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/014572179502100109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["10.1177\/014572179502100109"],"URL":"https:\/\/doi.org\/10.1177\/014572179502100109","relation":{},"ISSN":["0145-7217","1554-6063"],"issn-type":[{"value":"0145-7217","type":"print"},{"value":"1554-6063","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}